European Journal of Gynaecological Oncology. 2026; 47(3): 154-154. doi: 10.22514/ejgo.2026.051
Correction

Correction: Targeting CENPN to inhibit breast cancer progression: insights into cell growth and aerobic glycolysis modulation

Zhe Ye1, Qiuyan Lin2, Hualong Lin2, Yiwei Huang1,*,

1Department of Tumor Radiotherapy, The Third Affiliated Hospital of Wenzhou Medical University, 325200 Rui’an, Zhejiang, China

2Department of Oncology, The Third Affiliated Hospital of Wenzhou Medical University, 325200 Rui’an, Zhejiang, China

*Corresponding Author(s):yw_huang0711@163.com (Yiwei Huang)

History Published: 15 October 2026
Copyright:  ©2026 The Author(s). Published by MRE Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).

Collapse table of contents

Abstract

No abstract available.

Keywords:None.
PDF(224.21 kB)|EndNote (RIS)|BibTeX|RefMan|RefWorks

Cite this article

Zhe Ye, Qiuyan Lin, Hualong Lin, Yiwei Huang. Correction: Targeting CENPN to inhibit breast cancer progression: insights into cell growth and aerobic glycolysis modulation. European Journal of Gynaecological Oncology. 2026; 47(3): 154-154. doi: 10.22514/ejgo.2026.051

The authors regret that two references were incorrectly cited in the original publication [1]. The correct references are as follows:

Reference 22 should be replaced with: Jafari-Oliayi A, Dabiri S. SNHG6 203 RNA may be involved in the cell cycle progression in HER2-negative breast cancer cells. Iranian Journal of Pathology. 2022; 17: 251–260.

Reference 25 should be replaced with: Li X, Tang L, Chen Q, Cheng X, Liu Y, Wang C, et al. Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer. Chinese Medical Journal. 2022; 135: 2436–2445.

The authors apologize for any inconvenience caused.

References

Ye Z, Lin QY, Lin HL, Huang YW. Targeting CENPN to inhibit breast cancer progression: insights into cell growth and aerobic glycolysis modulation. European Journal of Gynaecological Oncology. 2024; 45: 147–157.

[Google Scholar]